Delivery Order SPE2DB20D1004-SPE2DB23FE8F2

Award Date 11/3/22
Potential Completion Date 11/4/22
Potential Value $1.3K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of JANUMET XR 50-1,000 MG TABLET 180S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on December 10, 2024, with a ceiling value of $4,533.58 and a completion date of December 11, 2024. This award is a delivery order under an Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA...
This federal contract award is for the supply of JANUMET XR 50-1,000 MG TABLET 180S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., which is a major pharmaceutical distributor. The contract has a ceiling value of $31,010.35 and is a delivery order under an Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to...
This federal contract award is for the delivery of JANUMET XR 100-1,000 MG TABLET 90S, a pharmaceutical product, to the Defense Logistics Agency (DLA) Troop Support Medical. The contract, awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., has a ceiling value of $2,078.40 and is a firm fixed-price delivery order. The contract has no set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award is for the delivery of JANUMET XR 50-500 MG TABLET 180S pharmaceutical products to the Defense Logistics Agency (DLA). The $3,487.96 firm fixed-price delivery order was issued to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on July 29, 2024, with a performance period ending on July 30, 2024. This award is part of an Indefinite Delivery Contract (IDC) valued at up to $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical, which...
This federal contract award is for the delivery of JANUMET XR 100-1,000 MG TABLET 90S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., doing business as Amerisourcebergen. The contract has a ceiling value of $1,290.84 and an ultimate completion date of December 1, 2023. This is a delivery order under a larger Indefinite Delivery Contract (IDC) that Cencora, Inc. holds...
This federal contract award is for the delivery of Janumet XR 50-1,000 mg tablets to the Defense Logistics Agency (DLA). The contract, valued at $1,452.12, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. This IDC, valued at up to $999,999,999.00, serves as the primary vehicle for...
This federal contract award is for the delivery of JANUMET XR 50-1,000 mg tablet 60s to the Defense Logistics Agency (DLA), a defense agency of the U.S. government. The contract has a ceiling value of $2,428.72 and is a firm fixed-price delivery order with an ultimate completion date of September 3, 2024. The prime contractor for this award is Amerisourcebergen Drug Corp, a major pharmaceutical distributor. This contract is a task order issued under a larger Indefinite Delivery Contract (IDC)...
This federal contract award is for the delivery of JANUMET XR 50-500 MG TABLET 60S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., for a not-to-exceed ceiling value of $1,542.20. The award is a delivery order under an Indefinite Delivery Contract (IDC) that Cencora, Inc. holds with the DLA Troop Support Medical, valued at up to $999,999,999.00. This IDC serves as the...
This federal contract award is for the delivery of JANUMET XR 50-1,000 MG TABLET 180S to the Defense Logistics Agency (DLA), a defense agency. The prime contractor is Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract has a ceiling value of $37,201.80 and is a firm fixed-price delivery order with a completion date of January 16, 2024. The contract was awarded on January 12, 2024, and there is no set-aside designation. Amerisourcebergen Drug Corp has a...
This federal contract award is for the delivery of JANUMET XR 50-1,000 mg tablets in quantities of 60 to the Defense Logistics Agency (DLA). The contract was awarded to the prime contractor, Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a firm fixed price and a ceiling value of $5,321.29. It is a delivery order contract with a completion date of July 18, 2023. The contract is not designated as a set-aside. Amerisourcebergen...
  • SPE2DB20D1004
    Indefinite Delivery Contract
  • SPE2DB20D1004-SPE2DB23FE8F2
    Delivery Order

This federal contract award is for the delivery of JANUMET XR 50-1,000 MG TABLET 180S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, through a Delivery Order (SPE2DB20D1004|SPE2DB23FE8F2) with a ceiling value of $1,276.64.

The award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through December 2025. This IDC serves as the primary vehicle for Cencora, Inc. to deliver a comprehensive range of pharmaceutical products and medical supplies to support military and veteran healthcare programs. The contract was awarded through full and open competition without any set-aside designation.

Generated 2/27/25, 11:17 AM